PMC:7352545 / 52535-52884
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T453 | 131-137 | Body_part | denotes | serine | http://purl.org/sig/ont/fma/fma82764 |
T454 | 192-196 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T455 | 252-257 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T206 | 101-109 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T207 | 166-175 | Disease | denotes | influenza | http://purl.obolibrary.org/obo/MONDO_0005812 |
T208 | 274-282 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T209 | 326-334 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T718 | 129-130 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T719 | 176-181 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T720 | 192-196 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T721 | 245-257 | http://purl.obolibrary.org/obo/CLO_0051840 | denotes | Calu-3 cells |
T722 | 245-257 | http://purl.obolibrary.org/obo/CLO_0051841 | denotes | Calu-3 cells |
T723 | 245-257 | http://purl.obolibrary.org/obo/CLO_0051842 | denotes | Calu-3 cells |
T724 | 245-257 | http://purl.obolibrary.org/obo/CLO_0051843 | denotes | Calu-3 cells |
T725 | 245-257 | http://purl.obolibrary.org/obo/CLO_0051844 | denotes | Calu-3 cells |
T726 | 245-251 | http://purl.obolibrary.org/obo/CLO_0002192 | denotes | Calu-3 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T46 | 21-24 | Chemical | denotes | Ser | http://purl.obolibrary.org/obo/CHEBI_17115|http://purl.obolibrary.org/obo/CHEBI_29999 |
T48 | 25-44 | Chemical | denotes | protease inhibitors | http://purl.obolibrary.org/obo/CHEBI_37670|http://purl.obolibrary.org/obo/CHEBI_60258 |
T50 | 34-44 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T51 | 53-70 | Chemical | denotes | camostat mesylate | http://purl.obolibrary.org/obo/CHEBI_135632 |
T76162 | 119-127 | Chemical | denotes | camostat | http://purl.obolibrary.org/obo/CHEBI_135632 |
T53 | 131-156 | Chemical | denotes | serine protease inhibitor | http://purl.obolibrary.org/obo/CHEBI_64926 |
T54 | 131-137 | Chemical | denotes | serine | http://purl.obolibrary.org/obo/CHEBI_17822 |
T55 | 138-156 | Chemical | denotes | protease inhibitor | http://purl.obolibrary.org/obo/CHEBI_37670|http://purl.obolibrary.org/obo/CHEBI_60258 |
T23789 | 147-156 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T43182 | 206-214 | Chemical | denotes | camostat | http://purl.obolibrary.org/obo/CHEBI_135632 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T510 | 0-349 | Sentence | denotes | For example, several Ser protease inhibitors such as camostat mesylate inhibit TMPRSS2–ACE2-involved SARS-CoV-2 entry. camostat, a serine protease inhibitor, reduces influenza virus titers in cell culture. camostat-treated TMPRSS2 inhibition in Calu-3 cells greatly reduces SARS-CoV viral titers and improves survival rate in SARS-CoV infected mice. |